Richard Galinier

Title: Richard Galinier: Innovator in Antimicrobial Peptides

Introduction

Richard Galinier is a notable inventor based in Perpignan, France. He has made significant contributions to the field of antimicrobial peptides, showcasing his expertise through various patents. His work focuses on innovative solutions to combat microbial threats.

Latest Patents

Richard Galinier holds 2 patents that highlight his research in antimicrobial peptides. His latest patents include a novel antimicrobial peptide known as Papillosin, which is derived from a marine invertebrate. This patent encompasses a gene coding for the peptide, a vector, a transformed organism, and a compound containing said organism. Additionally, he has developed an isolated peptide with the amino acid sequence FWGHIWNAVKRVGANALHGAVTGALS (SEQ ID No. 1), along with its derivatives and fragments containing at least 7 amino acids.

Career Highlights

Throughout his career, Richard has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Perpignan. His research has contributed to advancements in the understanding and application of antimicrobial peptides, making him a key figure in this scientific domain.

Collaborations

Richard Galinier has collaborated with notable colleagues, including Guillaume Mitta and Bernard Banaigs. These partnerships have further enriched his research and innovation in the field of antimicrobial peptides.

Conclusion

Richard Galinier's work in antimicrobial peptides exemplifies his commitment to innovation and scientific advancement. His patents and collaborations reflect his significant contributions to the field, positioning him as a leading inventor in this area.